Annual EBIT
-$40.27 M
+$4.86 M+10.77%
December 1, 2023
Summary
- As of February 7, 2025, CLYM annual earnings before interest & taxes is -$40.27 million, with the most recent change of +$4.86 million (+10.77%) on December 1, 2023.
- During the last 3 years, CLYM annual EBIT has fallen by -$28.51 million (-242.27%).
- CLYM annual EBIT is now -757.64% below its all-time high of -$4.70 million, reached on December 1, 2019.
Performance
CLYM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$11.73 M
+$44.64 M+79.19%
September 1, 2024
Summary
- As of February 7, 2025, CLYM quarterly earnings before interest & taxes is -$11.73 million, with the most recent change of +$44.64 million (+79.19%) on September 1, 2024.
- Over the past year, CLYM quarterly EBIT has increased by +$44.64 million (+79.19%).
- CLYM quarterly EBIT is now -629.60% below its all-time high of -$1.61 million, reached on June 1, 2020.
Performance
CLYM Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$76.23 M
-$6.73 M-9.68%
September 1, 2024
Summary
- As of February 7, 2025, CLYM TTM earnings before interest & taxes is -$76.23 million, with the most recent change of -$6.73 million (-9.68%) on September 1, 2024.
- Over the past year, CLYM TTM EBIT has dropped by -$6.73 million (-9.68%).
- CLYM TTM EBIT is now -3807.28% below its all-time high of -$1.95 million, reached on March 1, 2020.
Performance
CLYM TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CLYM EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.8% | +79.2% | -9.7% |
| 3 y3 years | -242.3% | +79.2% | -9.7% |
| 5 y5 years | -757.6% | +79.2% | -9.7% |
CLYM EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -12.9% | +10.8% | -290.4% | +79.2% | -284.2% | at low |
| 5 y | 5-year | -757.6% | +10.8% | -629.6% | +79.2% | -3807.3% | at low |
| alltime | all time | -757.6% | +10.8% | -629.6% | +79.2% | -3807.3% | at low |
Climb Bio EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$11.73 M(-79.2%) | -$76.23 M(+9.7%) |
| Jun 2024 | - | -$56.37 M(+1775.9%) | -$69.50 M(+250.3%) |
| Mar 2024 | - | -$3.00 M(-41.3%) | -$19.84 M(-50.7%) |
| Dec 2023 | -$40.27 M(-10.8%) | -$5.12 M(+2.4%) | -$40.27 M(-9.9%) |
| Sep 2023 | - | -$5.00 M(-25.5%) | -$44.71 M(-7.7%) |
| Jun 2023 | - | -$6.71 M(-71.4%) | -$48.45 M(-12.6%) |
| Mar 2023 | - | -$23.44 M(+145.3%) | -$55.44 M(+22.8%) |
| Dec 2022 | -$45.13 M | -$9.55 M(+9.2%) | -$45.13 M(-2.5%) |
| Sep 2022 | - | -$8.75 M(-36.2%) | -$46.28 M(-1.4%) |
| Jun 2022 | - | -$13.70 M(+4.3%) | -$46.92 M(+11.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$13.13 M(+22.7%) | -$41.92 M(+17.5%) |
| Dec 2021 | -$35.67 M(+203.2%) | -$10.70 M(+14.1%) | -$35.67 M(+15.4%) |
| Sep 2021 | - | -$9.38 M(+7.8%) | -$30.92 M(+29.9%) |
| Jun 2021 | - | -$8.71 M(+26.6%) | -$23.79 M(+42.5%) |
| Mar 2021 | - | -$6.88 M(+15.6%) | -$16.70 M(+41.9%) |
| Dec 2020 | -$11.77 M(+150.6%) | -$5.95 M(+163.3%) | -$11.77 M(+102.3%) |
| Sep 2020 | - | -$2.26 M(+40.5%) | -$5.82 M(+63.5%) |
| Jun 2020 | - | -$1.61 M(-17.6%) | -$3.56 M(+82.4%) |
| Mar 2020 | - | -$1.95 M | -$1.95 M |
| Dec 2019 | -$4.70 M | - | - |
FAQ
- What is Climb Bio annual earnings before interest & taxes?
- What is the all time high annual EBIT for Climb Bio?
- What is Climb Bio annual EBIT year-on-year change?
- What is Climb Bio quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Climb Bio?
- What is Climb Bio quarterly EBIT year-on-year change?
- What is Climb Bio TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Climb Bio?
- What is Climb Bio TTM EBIT year-on-year change?
What is Climb Bio annual earnings before interest & taxes?
The current annual EBIT of CLYM is -$40.27 M
What is the all time high annual EBIT for Climb Bio?
Climb Bio all-time high annual earnings before interest & taxes is -$4.70 M
What is Climb Bio annual EBIT year-on-year change?
Over the past year, CLYM annual earnings before interest & taxes has changed by +$4.86 M (+10.77%)
What is Climb Bio quarterly earnings before interest & taxes?
The current quarterly EBIT of CLYM is -$11.73 M
What is the all time high quarterly EBIT for Climb Bio?
Climb Bio all-time high quarterly earnings before interest & taxes is -$1.61 M
What is Climb Bio quarterly EBIT year-on-year change?
Over the past year, CLYM quarterly earnings before interest & taxes has changed by +$44.64 M (+79.19%)
What is Climb Bio TTM earnings before interest & taxes?
The current TTM EBIT of CLYM is -$76.23 M
What is the all time high TTM EBIT for Climb Bio?
Climb Bio all-time high TTM earnings before interest & taxes is -$1.95 M
What is Climb Bio TTM EBIT year-on-year change?
Over the past year, CLYM TTM earnings before interest & taxes has changed by -$6.73 M (-9.68%)